DYNE THERAPEUTICS, INC. (DYN)

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 3K shares of Dyne Therapeutics, Inc. (at $17.71 each, total $54K) Filed: May 05, 2026 | ID: 030662